By Andrew Silver SHANGHAI (Reuters) -Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, a Reuters review of Chinese regulator data showed, and threaten to add to drugmakers’ costs. China announced on Friday that it would raise its levies on imports of U.S. goods to 125%,…
We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other healthcare stocks. Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth potential,…
The year is 1998. While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the virus were receiving the life-saving treatment. Nowhere was the situation worse than in South Africa. The country had the highest global prevalence of the disease with nearly one in…
By Anirban Sen NEW YORK (Reuters) – Pfizer (PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter. The unit, now called Pfizer Hospital, was formed after Pfizer bought…
Hongkongers will have quicker and cheaper access to new medications when the Hospital Authority starts centralising new drug assessments and improving its procurement system to cut introduction times to its formulary by five months. The authority’s chief pharmacist, William Chui Chun-ming, said on Thursday doctors would no longer need to go through the assessment at…